For the Inventor, By the Inventor

Enter assignee name

Twi Biotechnology, Inc.

USPTO Granted Patents = 11

CIPO Patents = 4

EPO Patents = 3

Trademarks = 1

Forward Citations = 1

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Chih-Kuang Chen (8 out of 12 patents)

Wei-Shu Lu (8 out of 8 patents)

Carl Oscar Brown, Iii (5 out of 5 patents)

4. I-Yin Lin, Iii (5 out of 5 patents)

5. Jing-Yi Lee (4 out of 4 patents)

6. Chih-Ming Chen (3 out of 88 patents)

7. Po-Yuan Tseng (3 out of 3 patents)

8. Mannching Sherry Ku (3 out of 16 patents)

9. Chen-En Tsai (2 out of 2 patents)

10. Guang-Wei Lu (1 out of 2 patents)

11. Ling-Ying Liaw (1 out of 2 patents)

12. Fan-Lun Liu (1 out of 2 patents)

13. Shih-Fen Liao (1 out of 3 patents)

14. Chou-Hsiung Chen (1 out of 2 patents)

15. Yu-Han Kao (1 out of 4 patents)

11 patents: Sort by Forward Citations

1. 12161748 - Topical formulations comprising tofacitinib (2024-12-10),

2. 10675260 - Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders (2020-06-09),

3. 10512625 - Diacerein or rhein topical formulations and uses thereof (2019-12-24),

4. 10213418 - Therapeutic uses of berberine formulations (2019-02-26),

5. 10195170 - Methods for inhibiting expression of ASC, expression of NLRP3, and/or formation of NLRP3 inflammasome complex using diacerein or its analogs (2019-02-05),

6. 10154984 - Diacerein or Rhein topical formulations and uses thereof (2018-12-18),

7. 9744131 - Diacerein or rhein topical formulations and uses thereof (2017-08-29),

8. 9427432 - Berberine formulations and uses thereof (2016-08-30),

9. 8865689 - Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia (2014-10-21),

10. 8846758 - Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia (2014-09-30),

11. 8536152 - Methods of using diacerein as an adjunctive therapy for diabetes (2013-09-17),

Twi Biotechnology, Inc. is a cutting-edge biotech company focused on developing innovative solutions in the fields of molecular biology and genetic engineering. Our team of experts is dedicated to revolutionizing the way we approach healthcare and agriculture through advanced biotechnological research and development. Visit our website to learn more about our latest projects and discoveries.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

11 Patents

#422 in Taipei

#1,273 in Taiwan

#50,205 in the World

Twi Biotechnology, Inc.

Forward Citations = 1

21 inventors:

Chih-Kuang Chen (8 out of 12 patents)

Wei-Shu Lu (8 out of 8 patents)

Carl Oscar Brown, Iii (5 out of 5 patents)

4. I-Yin Lin, Iii (5 out of 5 patents)

5. Jing-Yi Lee (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…